gadolinium dtpa has been researched along with fibrin in 14 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Fuhrhop, RJ; Gaffney, PJ; Hall, CS; Lanza, GM; Scott, MJ; Song, SK; Wickline, SA; Yu, X | 1 |
| Hilger, T; Hoehn, M; Hossmann, KA; Niessen, F | 1 |
| Bulte, JW; Caruthers, SD; Chen, J; Gaffney, PJ; Lanza, GM; Miller, B; Robertson, JD; Song, SK; Wickline, SA; Winter, PM; Yu, X | 1 |
| Barrett, JA; Botnar, RM; Graham, PB; Hamilton, J; Johnstone, MT; Kolodziej, A; Laredo, J; Manning, WJ; Parsons, EC; Perez, AS; Quist, W; Vaidya, A; Weisskoff, RM; Wiethoff, AJ; Witte, S | 1 |
| Fuhrhop, RW; Gaffney, PJ; Hockett, F; Lanza, GM; Morawski, AM; Robertson, JD; Scott, MJ; Wickline, SA; Winter, PM; Yu, X | 1 |
| Caruthers, SD; Gaffney, PJ; Hockett, FD; Lamerichs, R; Lanza, GM; Neubauer, AM; Scott, MJ; Wickline, SA; Winter, PM | 1 |
| Jeong, EK; Jia, Z; Lu, ZR; Parker, D; Wu, X; Yang, T; Ye, F | 1 |
| Chiari, C; Domayer, SE; Dorotka, R; Mamisch, TC; Nehrer, S; Szomolanyi, P; Trattnig, S; Welsch, GH; Yayon, A | 1 |
| Daemen, MJ; Dirksen, A; Hackeng, TM; Heemskerk, JW; Heeneman, S; Herías, MV; Kooi, ME; Lobbes, MB; Miserus, RJ; Prinzen, L; van Engelshoven, JM; Van Suylen, RJ; van Zandvoort, MA | 1 |
| Beissner, RS; Morelli, JN; Runge, VM; Tweedle, M; Williams, JM | 1 |
| Caravan, P; Dai, G; Farrar, CT; Medarova, Z; Moore, A; Uppal, R | 1 |
| Caravan, P; Jacques, V; Kolodziej, AF; Overoye-Chan, K; Zhang, Z | 1 |
| Chopp, M; Ding, G; Jiang, Q; Li, L; Li, Q; Wei, M; Zhang, L; Zhang, Z | 1 |
| Laney, V; Li, Y; Lu, ZR | 1 |
14 other study(ies) available for gadolinium dtpa and fibrin
| Article | Year |
|---|---|
High-resolution MRI characterization of human thrombus using a novel fibrin-targeted paramagnetic nanoparticle contrast agent.
Topics: Antibodies, Monoclonal; Biotinylation; Contrast Media; Drug Evaluation, Preclinical; Fibrin; Gadolinium DTPA; Humans; Hydrocarbons, Chlorinated; Hydrocarbons, Fluorinated; In Vitro Techniques; Magnetic Resonance Imaging; Microscopy, Electron, Scanning; Particle Size; Plasma; Sensitivity and Specificity; Thrombosis; Time Factors | 2000 |
Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
Topics: Adenosine Triphosphate; Animals; Blood-Brain Barrier; Brain; Cerebral Hemorrhage; Cerebrovascular Circulation; Disease Models, Animal; Disease Progression; Elasticity; Extravasation of Diagnostic and Therapeutic Materials; Fibrin; Gadolinium DTPA; Infarction, Middle Cerebral Artery; Intracranial Thrombosis; Magnetic Resonance Angiography; Male; Rats; Rats, Wistar; Recombinant Proteins; Reperfusion; Stroke; Thrombin; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2003 |
Improved molecular imaging contrast agent for detection of human thrombus.
Topics: Contrast Media; Fibrin; Gadolinium DTPA; Humans; In Vitro Techniques; Magnetic Resonance Imaging; Oleic Acid; Oleic Acids; Phosphatidylethanolamines; Thrombosis | 2003 |
In vivo molecular imaging of acute and subacute thrombosis using a fibrin-binding magnetic resonance imaging contrast agent.
Topics: Acute Disease; Animals; Arteriosclerosis; Binding, Competitive; Contrast Media; Fibrin; Gadolinium DTPA; Magnetic Resonance Imaging; Male; Peptides; Rabbits; Thrombosis; Time Factors | 2004 |
Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles.
Topics: Arteriosclerosis; Biotinylation; Carotid Artery Diseases; Contrast Media; Emulsions; Endarterectomy, Carotid; Fibrin; Fluorine; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Nanostructures; Particle Size; Sensitivity and Specificity | 2004 |
In vitro demonstration using 19F magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla.
Topics: Animals; Dogs; Emulsions; Fibrin; Fluorine; Gadolinium DTPA; Hydrocarbons, Fluorinated; In Vitro Techniques; Nanostructures; Nuclear Magnetic Resonance, Biomolecular; Phantoms, Imaging; Thrombosis | 2006 |
A peptide targeted contrast agent specific to fibrin-fibronectin complexes for cancer molecular imaging with MRI.
Topics: Amino Acid Sequence; Animals; Cell Line, Tumor; Contrast Media; Fibrin; Fibronectins; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Mice; Neoplasms; Peptides, Cyclic | 2008 |
T2 mapping and dGEMRIC after autologous chondrocyte implantation with a fibrin-based scaffold in the knee: preliminary results.
Topics: Adolescent; Adult; Arthroscopy; Chondrocytes; Contrast Media; Female; Fibrin; Gadolinium DTPA; Humans; Image Enhancement; Knee Joint; Least-Squares Analysis; Magnetic Resonance Imaging; Male; Middle Aged; Tissue Scaffolds; Transplantation, Autologous; Treatment Outcome | 2010 |
Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.
Topics: alpha-2-Antiplasmin; Animals; Cadaverine; Contrast Media; Disease Models, Animal; Factor XIII; Factor XIIIa; Feasibility Studies; Fibrin; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Microscopy, Fluorescence, Multiphoton; Predictive Value of Tests; Pulmonary Embolism; Reproducibility of Results; Rhodamines; Thrombosis | 2009 |
Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model.
Topics: Animals; Area Under Curve; Brain Neoplasms; Contrast Media; Disease Models, Animal; Fibrin; Fluorescent Antibody Technique, Direct; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Organometallic Compounds; Rats; Rats, Inbred F344 | 2011 |
Molecular imaging of fibrin in a breast cancer xenograft mouse model.
Topics: Adenocarcinoma; Animals; Breast Neoplasms; Disease Models, Animal; Feasibility Studies; Female; Fibrin; Gadolinium; Gadolinium DTPA; Mice; Molecular Imaging; Peptides; Transplantation, Heterologous | 2012 |
Peptide optimization and conjugation strategies in the development of molecularly targeted magnetic resonance imaging contrast agents.
Topics: Amino Acid Sequence; Collagen; Contrast Media; Fibrin; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Molecular Sequence Data; Organometallic Compounds; Peptides; Staining and Labeling; Structure-Activity Relationship | 2014 |
MRI evaluation of BBB disruption after adjuvant AcSDKP treatment of stroke with tPA in rat.
Topics: Acute Disease; Animals; Blood-Brain Barrier; Brain; Capillary Permeability; Contrast Media; Disease Models, Animal; Drug Therapy, Combination; Fibrin; Fibrinolytic Agents; Gadolinium DTPA; Immunohistochemistry; Infarction, Middle Cerebral Artery; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Oligopeptides; Rats, Wistar; Tissue Plasminogen Activator | 2014 |
Targeted Contrast Agents for Magnetic Resonance Molecular Imaging of Cancer.
Topics: Amino Acids; Animals; Contrast Media; Fibrin; Fibronectins; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Molecular Imaging; Neoplasms; Oncogene Proteins; Organometallic Compounds; Peptides; Tumor Microenvironment | 2022 |